Table 4.

Tacrolimus as a single agent facilitates donor engraftment in mice conditioned with 200 or 100 cGy TBI

ReagentNo. chimeric% donorRange
TBI 200 cGy    
 Hamster IgG 0/10 0 ± 0 NA 
 Anti-CD40L 10/104-150 69 ± 54-150 64 -76 
 Tacrolimus 5/54-150 50 ± 44-150,4-151 46 -56  
 Anti-CD40L + tacrolimus 9/94-150 44 ± 64-150,4-151 39 -55  
TBI 100 cGy    
 Hamster IgG 0/10 0 ± 0 NA 
 Anti-CD40L 10/104-150 50 ± 64-150 40 -56 
 Tacrolimus 10/104-150 44 ± 74-150 33 -53  
 Anti-CD40L + tacrolimus 9/94-150 42 ± 74-150,4-151 28 -50 
ReagentNo. chimeric% donorRange
TBI 200 cGy    
 Hamster IgG 0/10 0 ± 0 NA 
 Anti-CD40L 10/104-150 69 ± 54-150 64 -76 
 Tacrolimus 5/54-150 50 ± 44-150,4-151 46 -56  
 Anti-CD40L + tacrolimus 9/94-150 44 ± 64-150,4-151 39 -55  
TBI 100 cGy    
 Hamster IgG 0/10 0 ± 0 NA 
 Anti-CD40L 10/104-150 50 ± 64-150 40 -56 
 Tacrolimus 10/104-150 44 ± 74-150 33 -53  
 Anti-CD40L + tacrolimus 9/94-150 42 ± 74-150,4-151 28 -50 

B6 mice were irradiated with 200 or 100 cGy TBI as indicated on day − 1 and infused with 40 × 106 BALB/c BM on day 0. Reagents were administered from day − 1 through day 14. PBLs were typed for percentage of donor-host at 3.5 months after BMT. Chimeric is defined as more than 3% donor PBLs. Percentage donor is defined as average percentage donor cells of all mice in the group ± 1 SD. Range indicates lowest to highest level of percentage donor cells in engrafted mice. NA indicates not applicable.

F4-150

P < .001 compared with hamster IgG.

F4-151

P ≤ .02 compared with anti-CD40L as a single agent.

Close Modal

or Create an Account

Close Modal
Close Modal